Vertex Pharmaceuticals EVP Sells Nearly 1,000 Shares

Joy Liu, an executive vice president at the biotech firm, sold almost $440,000 worth of company stock.

Apr. 4, 2026 at 11:03am

Got story updates? Submit your updates here. ›

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) EVP Joy Liu sold 978 shares of the company's stock on April 1st. The shares were sold at an average price of $449.17, resulting in a total transaction value of $439,288.26. Following the sale, Liu directly owns 21,833 shares in the company, valued at $9.8 million.

Why it matters

Insider transactions, such as stock sales by company executives, can provide insights into management's views on a company's prospects. Vertex is a leading biotech firm focused on developing treatments for serious diseases like cystic fibrosis, so this transaction is noteworthy for investors tracking the company's performance and leadership.

The details

The stock sale was executed under a pre-arranged Rule 10b5-1 trading plan, which allows company insiders to schedule stock transactions in advance and avoid allegations of insider trading. Vertex's shares opened at $438.71 on Friday, down from a 52-week high of $510.77.

  • The stock sale occurred on Wednesday, April 1st, 2026.
  • Vertex's shares have traded between $362.50 and $510.77 over the past 52 weeks.

The players

Joy Liu

An executive vice president at Vertex Pharmaceuticals.

Vertex Pharmaceuticals Incorporated

A Boston-based biotechnology company focused on the discovery, development and commercialization of therapies for serious diseases, particularly cystic fibrosis.

Got photos? Submit your photos here. ›

The takeaway

This stock sale by a Vertex Pharmaceuticals executive provides a data point for investors to consider as they evaluate the company's leadership, strategy and future prospects in the competitive biotech industry.